Sato et al.
with BzCl (0.26 mL, 2.2 mmol) and a catalytic amount of
DMAP in pyridine (1.5 mL) at 50 °C for 18 h. After the usual
workup, the residue was purified by column chromatography
on silica gel (hexane/Et2O 3/1) to give an inseparable mix-
ture of 9-I and 9-T (77 mg, total yield 95%, ratio of 4.3:1).
To a mixture of benzoate 9-I and 9-T (37 mg, 0.11 mmol,
ratio of 4.3:1) in 1,4-dioxane-H2O (10:1, 1.5 mL) were added
PdCl2 (1.9 mg, 0.01 mmol) and CuCl (1.4 mg, 0.01 mmol), and
the mixture was stirred at room temperature for 1.5 h under
an atmosphere of oxygen. The mixture was diluted with Et2O,
and 10% HCl aq solution was added to the mixture. The
aqueous layer was extracted with Et2O, and the organic layer
was washed with brine and dried over Na2SO4. After re-
moval of the solvent, the residue was purified by column
chromatography on silica gel (hexane/EtOAc 5/1 to 2/1) to give
12 (8 mg, 21%), and unchanged 9-I (29 mg, 79%) was
recovered.
Sp ectr a l d a ta for 9-I: IR (neat) 1736, 1720, 1654, 1602,
1114 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.53 (dd, J ) 6.3, 1.3
Hz, 3 H), 2.37 (dd, J ) 13.6, 7.8 Hz, 1 H), 2.53 (dd, J ) 13.6,
11.8 Hz, 1 H), 2.57 (dd, J ) 15.2, 1.7 Hz, 1 H), 2.63 (dd, J )
15.2, 4.4 Hz, 1 H), 2.77 (m, 1 H), 3.56 (s, 3 H), 3.68 (s, 3 H),
5.34 (m, 1 H), 5.37 (ddq, J ) 15.3, 7.3, 1.3 Hz, 1 H), 5.50 (dq,
J ) 15.3, 6.3 Hz, 1 H), 7.30-7.41 (m, 2 H), 7.48 (m, 1 H), 7.88-
7.93 (m, 2 H); EI-LRMS m/z 346 (M+), 315, 278, 241, 224, 164,
105, 77, 59; EI-HRMS calcd for C19H22O6 346.1417, found
346.1402; [R]23D +26.8 (c 1.66, CHCl3, 73% ee) (for (1S,2S)-9-I
derived from 7c-I in Table 3, run 4)
After removal of the solvent, the residue was purified by
column chromatography on silica gel (hexane/Et2O 5/1) to give
the benzoate as a colorless oil (71 mg, 58%). IR (neat) 1736,
1722, 1654, 1602, 1270 cm-1; 1H NMR (270 MHz, CDCl3) δ
1.65 (d, J ) 6.3 Hz, 3 H), 2.02 (dd, J ) 13.5, 9.0 Hz, 1 H), 2.44
(dd, J ) 14.5, 5.1 Hz, 1 H), 2.76 (dd, J ) 13.5, 7.9 Hz, 1 H),
2.86 (dd, J ) 14.5, 6.8 Hz, 1 H), 2.88 (m, 1 H), 3.01 (s, 3 H),
3.75 (s, 3 H), 5.12 (m, 1 H), 5.43 (dd, J ) 15.4, 7.3 Hz, 1 H),
5.58 (dq, J ) 15.4, 6.3 Hz, 1 H), 7.43 (dd, J ) 7.7, 7.7 Hz, 2
H), 7.55 (dd, J ) 7.7, 7.7 Hz, 1 H), 8.00 (d, J ) 7.7 Hz, 2 H);
EI-LRMS m/z 346 (M+), 315, 224, 164, 105, 77; EI-HRMS calcd
for C19H22O6 346.1416, found 346.1438; [R]23 -8.60 (c 2.42,
D
CHCl3, 26% ee).
(1R,2S)-4,4-Bism eth oxyca r bon yl-2-[(1E)-p r op en yl]cy-
clop en ta n -1-ol (14-I). According to the procedure described
above, 14-I was prepared in 98% yield (48 mg) by the reaction
of the above benzoate (71 mg, 0.21 mmol) and K2CO3 (142 mg,
1.0 mmol) in CH3OH (3 mL) at room temperature for 36 h
followed by treatment of CH2N2. IR (neat) 3432, 1734, 1640,
1
1168, 1076 cm-1; H NMR (270 MHz, CDCl3) δ 1.68 (dd, J )
6.5, 1.2 Hz, 3 H), 1.05 (dd, J ) 13.6, 10.1 Hz, 1 H), 2.01 (br d,
J ) 4.4 Hz, 1 H), 2.16 (dd, J ) 14.0, 7.2 Hz, 1 H), 2.43 (m, 1
H), 2.57 (dd, J ) 13.6, 7.7 Hz, 1 H), 2.63 (dd, J ) 14.0, 7.2 Hz,
1 H), 3.73 (s, 3 H), 3.75 (s, 3 H), 3.89 (m, 1 H), 5.31 (ddq, J )
15.2, 7.8, 1.2 Hz, 1 H), 5.58 (ddq, J ) 15.2, 1.0, 6.5 Hz, 1 H);
EI-LRMS m/z 224 (M+ - H2O), 164, 105, 59; EI-HRMS calcd
for C12H16O4 224.1048 (M+ - H2O), found 224.1051; [R]24
-3.23 (c 1.93, CHCl3, 26% ee).
D
Sp ectr a l d a ta for 12: IR (neat) 1734, 1720, 1718, 1654,
1602, 1114 cm-1 1H NMR (400 MHz, CDCl3) δ 2.10 (s, 3
;
Con ver sion of 14-I in to (S)-MTP A Ester 15-I. To a
solution of 14-I (28 mg, 0.11 mmol, 26% ee) in CH2Cl2 (1.5
mL) were added DCC (36 mg, 0.17 mmol), (S)-(-)-R-methoxy-
R-(trifluoromethyl)phenylacetic acid (40 mg, 0.17 mmol), and
DMAP (22 mg, 0.18 mmol), and the mixture was stirred at
room temperature for 15.5 h. The mixture was diluted with
Et2O, 10% HCl aq solution was added to the mixture, and
the solution was stirred at room temperature for 1 h. The
aqueous layer was extracted with Et2O, and the organic layer
was washed with a saturated NaHCO3 aq solution and brine
and dried over Na2SO4. After removal of the solvent, the
residue was purified by column chromatography on silica gel
(hexane/Et2O 5/1 to 3/1) to give two diastereomers as an
inseparable mixture (46 mg, 87%, 26% de). The NMR spec-
tral data (including COSY spectrum) of the mixture were
fully considered by application of the improved Mosher’s
method, and it indicates that (1R,2S)-15-I was a major
diastereomer. (1R,2S)-15-I: 1H NMR (500 MHz, CDCl3) δ 1.61
(d, J ) 6.4 Hz, 3 H), 1.97 (dd, J ) 13.6, 10.5 Hz, 1 H), 2.38
(dd, J ) 14.4, 6.5 Hz, 1 H), 2.58 (dd, J ) 13.6, 7.8 Hz, 1 H),
2.68 (m, 1 H), 2.83 (dd, J ) 14.4, 7.4 Hz, 1 H), 3.53 (s, 3 H),
3.69 (s, 3 H), 3.74 (s, 3 H), 5.14 (ddd, J ) 7.4, 7.4, 6.5 Hz, 1
H), 5.30 (dd, J ) 15.3, 8.1 Hz, 1 H), 5.43 (dq, J ) 15.3, 6.4 Hz,
1 H), 7.36-7.43 (m, 3 H), 7.49-7.51 (m, 2 H). (1S,2R)-15-I:
1H NMR (500 MHz, CDCl3) δ 1.66 (d, J ) 6.3 Hz, 3 H), 1.95
(dd, J ) 13.6, 11.7 Hz, 1 H), 2.23 (dd, J ) 14.5, 6.4 Hz, 1 H),
2.63 (dd, J ) 13.6, 7.9 Hz, 1 H), 2.77 (m, 1 H), 2.85 (dd, J )
14.5, 7.3 Hz, 1 H), 3.53 (s, 3 H), 3.69 (s, 3 H), 3.74 (s, 3 H),
5.12 (ddd, J ) 7.3, 7.3, 6.4 Hz, 1 H), 5.30 (dd, J ) 15.1, 7.9
Hz, 1 H), 5.56 (dq, J ) 15.1, 6.3 Hz, 1 H), 7.36-7.43 (m, 3 H),
7.49-7.51 (m, 2 H).
H), 2.39 (dd, J ) 13.6, 11.1 Hz, 1 H), 2.49-2.52 (m, 2 H), 2.63
(dd, J ) 15.2, 1.2 Hz, 1 H), 2.67-2.78 (m, 3 H), 3.62 (s, 3 H),
3.75 (s, 3 H), 5.51 (m, 1 H), 7.42-7.49 (m, 2 H), 7.57 (m, 1 H),
7.94-7.99 (m, 2 H); EI-LRMS m/z 363 (M+ + H), 362 (M+),
331, 319, 305, 240, 198, 183, 105, 77; EI-HRMS calcd for
C
19H23O7 (M+ + H) 363.1444, found 363.1416; [R]24 -3.7 (c
D
1.36, CHCl3, 86% ee) (for (1S,2S)-12 derived from 7e-T in Table
4, run 3)
The enantiomeric excess of 9-I or 12 was determined by
HPLC analysis [DAICEL CHIRALPAK AD (hexane/2-propanol
9/1) or DAICEL CHIRALPAK AD (hexane/2-propanol 9/1),
respectively]. The enantiomeric excesses of other cyclized
products in Tables 2-4 were determined by HPLC analysis
after transformation to 9-I and 12 by similar procedures as
those for 7a -I and 7a -T.
Typ ica l P r oced u r e for Deter m in a tion of Absolu te
Con figu r a tion s of th e Cyclized P r od u cts 7-I a n d 7-T
(Sch em es 8 a n d 9). (1S,2S)-4,4-Bism eth oxyca r bon yl-2-
[(1E)-p r op en yl]cyclop en ta n -1-ol (13-I). To a solution of 9-I
(341 mg, 0.98 mmol, 26% ee) in CH3OH (10 mL) was added
K2CO3 (677 mg, 4.9 mmol), and the mixture was stirred at
room temperature for 20 h. After the usual workup, the crude
material was treated with an excess amount of CH2N2 in Et2O,
and the mixture was concentrated in vacuo. The residue was
purified by column chromatography on silica gel (hexane/
EtOAc 4/1) to give 13-I as a colorless oil (225 mg, 95%). IR
(neat) 3526, 1732, 1654, 1198, 1142 cm-1; 1H NMR (400 MHz,
CDCl3) δ 1.71 (dd, J ) 6.2, 1.3 Hz, 3 H), 1.82 (br d, J ) 3.4
Hz, 1 H), 2.31-2.45 (m, 3 H), 2.49 (dd, J ) 14.7, 1.7 Hz, 1 H),
2.61 (m, 1 H), 3.72 (s, 3 H), 3.75 (s, 3 H), 4.15 (m, 1 H), 5.50
(dq, J ) 15.5, 1.3 Hz, 1 H), 5.61 (dq, J ) 15.5, 6.2 Hz, 1 H);
EI-LRMS m/z 242 (M+), 224, 174, 164, 145, 113, 105, 68, 59;
EI-HRMS calcd for C12H18O5 242.1154, found 242.1176; [R]22
+7.27 (c 1.15, CHCl3, 26% ee).
D
Other spectral data of a mixture of (1R,2S)-15-I and (1S,2R)-
15-I: IR (neat) 1738, 1736, 1654, 1252 cm-1; EI-LRMS m/z
427 (M+ - OMe), 224, 189, 165, 105, 77, 59; EI-HRMS calcd
for C21H22F3O6 (M+ - OMe) 427.1368, found 427.1379.
(1R,2S)-1-Ben zoyloxy-4,4-bism eth oxyca r bon yl-2-[(1E)-
p r op en yl]cyclop en ta n e. To a solution of 13-I (85 mg, 0.35
mmol, 26% ee) in THF (2 mL) were added PPh3 (185 mg, 0.70
mmol), benzoic acid (102 mg, 0.46 mmol), and DEAD (136 mg,
0.78 mmol), and the mixture was stirred at room temperature
for 4 h. To the mixture was added a saturated NaHCO3 aq
solution, and the aqueous layer was extracted with Et2O. The
organic layer was washed with brine and dried over Na2SO4.
Con ver sion of (1S,2S)-9-I in to (1S,2S)-12. According to
a procedure similar to that described above, the crude product,
which was prepared from (1S,2S)-9-I (40 mg, 0.12 mmol, 46%
ee), PdCl2 (2.0 mg, 0.011 mmol), and CuCl (1.4 mg, 0.014
mmol) in DMF-H2O (10:1, 1.5 mL) at room temperature for
9316 J . Org. Chem., Vol. 67, No. 26, 2002